Navigation Links
CEVA Group Plc Reports Quarter 3, 2007 Results
Date:11/29/2007

First Release Following Extension of Service Offering

CEVA Third Quarter 2007 Results

HOOFDDORP, The Netherlands, November 29 /PRNewswire/ -- CEVA Group Plc released its Quarter 3, 2007 Interim Financial Statements today. These statements include the following highlights:

- First presentation of results following the EGL acquisition on 2 August 2007

- EBITDA increased to EUR86.9 million from EUR(4.3) million in Q3 2006

- Adjusted EBITDA improved to EUR93.1million from EUR57.5 million in Q3 2006
- Cash position at the 30 September 2007 of EUR216.9 million

- Solid financing structure with medium to long term maturity dates.

CEVA Group Plc delivered the following results:

Three months ended Sep 30 Nine months ended Sep 30

2007 2006 2007 2006

Net sales EUR1,331.3m EUR840.4m 58.4% EUR3,097.7m EUR2,587.1m 19.7%

EBITDA EUR86.9m EUR(4.3)m - EUR186.9m EUR66.9m 179.4%

% sales 6.5% (0.5)% 6.0% 2.6%

Adjusted EUR93.1m EUR57.5m 80.9% EUR202.3m EUR151.7m 41.2%

EBITDA*

% sales 7.0% 6.8% 6.5% 5.9%

*Adjustments in 2007 relate mainly to EGL merger costs and Contract Logistics rebranding and separation costs.

** The results presented include three months Contract Logistics and two months EGL.

Our Contract Logistics and Freight Management business on a stand-alone basis delivered the following results:

- Contract Logistics organic results excluding the impact of the EGL acquisition:

Three months ended Sep 30 Nine months ended Sep 30

2007 2006 2007 2006

Net sales EUR833.5m EUR829.5m 0.5% EUR2,579m EUR2,553.9m 1.0%

EBITDA EUR63.3m
'/>"/>

SOURCE CEVA Group Plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
4. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
5. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
6. UTC Power Acquires Dome-Tech Group
7. Sutter Health Medical Groups Among the Best for Health Care Quality
8. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
9. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
10. AMERIGROUP to Acquire Memphis Health Plan
11. Securians Minnesota Life Continues to Climb Group Life Rankings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Wallingford, CT (PRWEB) June 03, 2015 ... devices, announces today since June has been designated as ... Company commends the Tucson, AZ. Police Department for its ... that its personnel utilized their Individual First Aid Kits ... help civilians involved in shootings, stabbings or traffic accidents. ...
(Date:6/3/2015)... Researchers at the University of Western Australia compared ... tried-and-true marker mesothelin is the best option available. Surviving ... Click here to read it now. , ... Diseases say, even though a mesothelin test can sometimes ... fibulin-3 for identifying mesothelioma. , “Preliminary results on ...
(Date:6/3/2015)... According to an article published on ... fake oxycodone pills which actually contained the potent addictive ... legitimate, and even sported the “A/215” imprint common on ... 30 mg oxycodone to be exceptionally critical of their ... them illegally on the street. Fentanyl is an opiate-based ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Fourroux Prosthetics, ... Duluth, GA will celebrate its grand opening with a ... The first prosthetic center of its kind in the ... family unmatched care and outcomes through use of patented ... CPO & CEO of Fourroux Prosthetics, states, “Our goal ...
(Date:6/3/2015)... MN (PRWEB) June 03, 2015 DailyEndorphin ... wellness "events" programming module. With this highly configurable ... run and report on many components of its wellness ... at no additional charge. , With this new module, ... Integrate DE challenges, (2) Create participant surveys, (3) Continually ...
Breaking Medicine News(10 mins):Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:DailyEndorphin Launches Wellness "Events" Portal 2
... Simple computerized alerts can help curb the impulse ... study in the August issue of Journal ... clinicians received computerized alerts, which compared medication brands, ... heavily marketed sleep medications to comparable generic equivalents. ...
... The median profit margin of U.S. hospitals increased ... more than 8 percent in the second quarter of 2009, ... by Thomson Reuters. , The recovery has been broad-based, with ... hospitals, teaching hospitals and major teaching hospitals -- showing positive ...
... ... development of scientists and science trainees who hope to translate laboratory research into clinical ... CTSciNet, the Clinical and Translational Science Network. , ... (PRWEB) November 6, 2009 -- Launched October 20 ...
... ... of lung cancer has been launched at TheFaceofLungCancer.org. The site provides a community for ... , ... 9, 2009 -- With health care as the number one issue in the public ...
... , ... One of the top cosmetic surgeons in ... has recently published his new, highly acclaimed manuscript of facial rejuvenation ... certified Facial Plastic and Reconstructive Surgeon, Dr. Bassichis’ innovative approach combines ...
... women ages 18 to 68 found that lubricant use during ... ratings of pleasurable and satisfying sex. Personal lubricants ... of sexual intercourse and to reduce the risk of vaginal ... use of lubricants or associated vaginal symptoms. The ...
Cached Medicine News:Health News:Computerized support keeps prominence of name brand drugs at bay 2Health News:Hospital Financials Have Recovered to Pre-Recession Levels, According to Thomson Reuters Study 2Health News:Hospital Financials Have Recovered to Pre-Recession Levels, According to Thomson Reuters Study 3Health News:Social Network for Translational Scientists Launched 2Health News:Social Network for Translational Scientists Launched 3Health News:Social Network for Translational Scientists Launched 4Health News:The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy 2Health News:The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy 3Health News:Dallas Facial Plastic Surgeon Publishes Cutting-Edge Novel Approach To Facelift Technique 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3
(Date:6/3/2015)... DUBLIN , June 02, 2015 ... the addition of the "2015 Strategies in ... to their offering. Highlights of the ... of the US tumor marker testing market. ... practice, as well as key economic, regulatory, demographic, ...
(Date:6/3/2015)... -- AVT, Inc. (OTC Markets: AVTC) ( www.autoretail.com ), ... that their customer, Pharmabox, has introduced the world,s 1 ... over 140 top selling brand name items typically found ... Aid-type store. As published in the ... -based Pharmabox worked with AVT to develop a ...
(Date:6/3/2015)... June 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... and license agreement with AbbVie (NYSE: ABBV ... compounds with Halozyme,s ENHANZE ™ platform. ... Halozyme will receive an initial $23 million payment, ... for each of up to nine collaboration targets. ...
Breaking Medicine Technology:United States Strategies in the Tumor Marker Testing Market 2015 2Pharmabox Introduces New Concept with a Boldly Designed Automated Retailing System 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3
... Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX) (the "Company") announced ... financing.  The new capital will primarily be used to fund working ... , , ... has been appointed as President, Chief Executive Officer and Board ...
... PRINCETON, N.J. , June 25 Soligenix, ... a late-stage biopharmaceutical company, announced today the publication of ... of Vaccine , which describes protection from mucosal ... of RiVax™, the Company,s vaccine against ricin toxin. The ...
Cached Medicine Technology:Patient Safety Technologies Completes $6.0 Million Equity Financing 2Patient Safety Technologies Completes $6.0 Million Equity Financing 3Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 2Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 3Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 4Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 5Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 6Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 7
VIKIA Rota-Adeno is a rapid, qualitative, chromatographic immunoassay which simultaneously detects rotaviruses and adenoviruses in stool specimens. Rotaviruses and adenoviruses are responsible for,th...
A direct enzyme immunoassay for detection of gr. A rotavirus in fecal specimens....
The ELISA test is used for detection and semi quantitation of igG antibodies to proteinase 3(PR3) in human sera, as an aid to the diagnosis is of Wegener's granulomatosis....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: